Publications:

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy.

Molecular Therapy. Nucleic Acids

Wang, Hao H; Gao, Yuzhen Y; Vafaei, Somayeh S; Yu, Qiaoyan Q; Zhang, Jun J; Wang, Liangjing L

Publication Date: 2022-03-08

Variant appearance in text: BRAF: A42R

PubMed Link: 35036055

Variant Present in the following documents:

• mmc2.pdf

View BVdb publication page

Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine

Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L

Publication Date: 2018-07-27

Variant appearance in text: BRAF: A42R

PubMed Link: 30053901

Variant Present in the following documents:

• 13073_2018_564_MOESM2_ESM.xlsx, sheet 8
• 13073_2018_564_MOESM2_ESM.xlsx, sheet 2

View BVdb publication page